Literature DB >> 3200163

Nutritionally variant streptococci develop ultrastructural abnormalities during experimental endocarditis.

C Frehel1, R Hellio, A C Cremieux, A Contrepois, A Bouvet.   

Abstract

Nutritionally variant streptococci (NVS) are fastidious micro-organisms responsible for most of the so-called negative blood culture endocarditis. In patients, the relative resistance of these bacteria to antibiotic treatment may be relevant to bacterial alterations in infected tissues. We used here a rabbit experimental model of endocarditis in order to examine, under scanning and transmission electron microscope, the NVS ultrastructure inside cardiac vegetations and to follow alterations at the different stages of the disease. In the early phase (day 7) of endocarditis, NVS were found dispersed inside vegetations and exhibited a typical streptococcal morphology similar to that observed during an in vitro balanced growth. In contrast, on day 11 and day 18, bacteria were found gathered as large and numerous clusters, in which they exhibited abnormal ultrasturctural features similar to those previously described during in vitro unbalanced growth. At this stage, ruthenium red staining revealed a large amount of exopolysaccharide surrounding the bacteria. None of these bacterial alterations were observed inside the vegetations of rabbits treated from day 7 to day 11 with penicillin or vancomycin. These abnormalities might be mainly related to nutrient limitation inside the clusters and could contribute to the pathogenicity of these micro-organisms.

Entities:  

Mesh:

Year:  1988        PMID: 3200163     DOI: 10.1016/0882-4010(88)90085-x

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  7 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 2.  Nutritionally variant streptococci.

Authors:  K L Ruoff
Journal:  Clin Microbiol Rev       Date:  1991-04       Impact factor: 26.132

3.  Treated bacterial endocarditis as a histological mimic of fungal infection.

Authors:  D E Roskell; I C Bowler; P Barnes
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

4.  Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.

Authors:  A C Cremieux; A Saleh-Mghir; J M Vallois; B Maziere; M Muffat-Joly; C Devine; A Bouvet; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

5.  Dextranase enhances antibiotic efficacy in experimental viridans streptococcal endocarditis.

Authors:  A S Mghir; A C Cremieux; R Jambou; M Muffat-Joly; J J Pocidalo; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

Review 6.  From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.

Authors:  David Lebeaux; Ashwini Chauhan; Olaya Rendueles; Christophe Beloin
Journal:  Pathogens       Date:  2013-05-13

7.  The Inactivation of a New Peptidoglycan Hydrolase Pmp23 Leads to Abnormal Septum Formation in Streptococcus pneumoniae.

Authors:  Pagliero E; Dublet B; Frehel C; Dideberg O; Vernet T; Di Guilmi Am
Journal:  Open Microbiol J       Date:  2008-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.